These data suggest a role for EZH2-dependent epigenetic regulation in the maintenance of an undifferentiated and stem-like phenotype in Ewing sarcoma, as has been reported in prostate tumors, breast cancer and glioblastoma [91,92]. This evidence concerns the gene EZH2 and Ewing sarcoma.